Evidence map›Paper›PMID 41117768›Full record

ArticleThe Laryngoscope2026

Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.

Benjamin Palatnik, Lindsey Mortensen, Aleksandr Palatnik, Beverly R Wuertz, Frank G Ondrey

Abstract read
In one paragraph

Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjamin PalatnikUniversity of Minnesota Medical School-Twin Cities, Minneapolis, Minnesota, USA.ORCID 0009-0009-3471-3715
Lindsey MortensenUniversity of Minnesota Medical School-Twin Cities, Minneapolis, Minnesota, USA.
Aleksandr PalatnikItec Engineering LLC, Pewaukee, Wisconsin, USA.
Beverly R WuertzDepartment of Otolaryngology, University of Minnesota, Minneapolis, Minnesota, USA.
Frank G OndreyDepartment of Otolaryngology, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-4951-9335

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8M
Pioglitazone-Metformin Combination Treatment for High Risk Oral PreneoplasiaR01CA254270 · NCI · UNIVERSITY OF MINNESOTA · PI ONDREY, FRANK G. · 2022 to 2025
$1.7M
NCATS NIH HHS UM1 TR004405NCI NIH HHS R01 CA254270
6 · The paper itself

Abstract

objectivesOral potentially malignant disorders (OPMDs) are local and systemic conditions that can result in oral malignancies. We have had an OPMD surveillance program for 25 years covering over 30% of our state's population. More recent electronic health record search techniques have allowed us to analyze over 1500 patients in over a 10-year period, approximately 20% of total referrals.

methodsElectronic health record (EHR) information was queried for 24 International Classification of Disease (ICD) 9 and 10 codes to generate a de-identified data set. Charts within this data set were cross-referenced against 79 ICD9/10 codes corresponding to oral and oropharyngeal cancers. The time course of conversion and frequencies of precancerous and cancerous lesions was assessed.

resultsOf 4496 unique patients seen, 1535 patient records met inclusion criteria. Seventy two patients showed cancerous conversion (4.69%), with 55 (3.58%) before 5 years, and 17 (1.11%) after a 5-year surveillance period. Leukoplakia and OLP patients constituted 34.7% of conversions, though other lesions/diseases of the tongue/oral mucosa showed conversion. Tongue cancers were the most represented carcinomas, followed by carcinomas of the oropharynx.

conclusionWe discovered overall rates of malignant conversion within the broad range reported in the world literature (0%-60%). Importantly, this living data set can be repeatedly queried over time to discover significant malignant conversions, potentially over decades. With significant conversions occurring after 5 years, OPMD conditions likely require longer-term surveillance like colon, breast, or other cancers. LEVEL OF EVIDENCE: 3:

Indexed as

Cell Transformation, NeoplasticMouth NeoplasmsPrecancerous ConditionsAdultAgedAged, 80 and overElectronic Health RecordsFemaleHumansLongitudinal StudiesMaleMiddle AgedRetrospective Studiesepidemiological studieshead and neckoral cavity

Identifiers

PMID41117768
PMCPMC12993112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.